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Endotoxin is a lipopolysaccharide (LPS) constituent
of the cell wall of Gram-negative bacteria. During
severe bacterial infection with endotoxemia and sepsis,
the hemodynamic condition can be severely dampened
due to the altered myocardial and vascular function.
Previous animal experiments have yielded controversial
results with regard to the influence of endotoxin on
vascular function. For instance, endotoxin elicited a
decrease in vascular pressure and resistance in the sys-
temic circulation and, at the same time, an increase in
vascular resistance in the pulmonary circulation of rats.1
In LPS-treated rabbits, vascular hyporesponsiveness
to norepinephrine was found in the ear artery, a
peripheral large artery, but not in the renal vasculature,
a resistance vascular bed.2
Endotoxemia is a well-known phenomenon in liver
cirrhosis because of the impaired ability of Kupffer cells
to remove gut-derived endotoxin. Furthermore, endo-
toxin is prone to get into the systemic circulation via
the portal–systemic collateral vascular bed, the unique
vasculature that develops in an attempt to divert the
stagnant portal blood flow. A cytokine cascade with
vasoactive substance release can be triggered by bac-
terial infection and endotoxemia, which leads to an
increase in variceal pressure, impaired hemostasis, and
a tendency to variceal hemorrhage.3 In addition, endo-
toxemia in cirrhotic rats with ascites can stimulate forma-
tion of nitric oxide (NO; a vascular endothelium-derived
vasodilatory substance), directly or indirectly via cyto-
kine cascade.4 It has been demonstrated that NO con-
tributes to splanchnic vascular hyporesponsiveness to
vasoconstrictors in portal hypertensive rats with acute
hemorrhage.5 In fact, a previous study has indicated
that bacterial infection is the single identifiable risk fac-
tor for rebleeding after endoscopic treatment for variceal
hemorrhage in cirrhotic patients.6 A randomized trial
has further demonstrated that antibiotic prophylaxis
after endoscopic therapy prevented rebleeding and de-
creased the amount of blood transfused for patients
with acute gastroesophageal variceal hemorrhage.7
Clarification of the vascular derangements induced
by bacterial infection, therefore, is a prerequisite to over-
come the adverse impacts of sepsis in cirrhosis and por-
tal hypertension. With the aim of investigating the
vascular responsiveness modified by sepsis, Liao et al
designed a series of experiments to survey the relevant
influences.8 They found that, compared with the base-
line portal hypertensive group, cecum ligation and punc-
ture (CLP; an animal model of sepsis) elicited enhanced
NO production and poorer superior mesenteric arterial
vascular responsiveness at 6 and 18 hours after CLP.
This finding was supported by evidence of increased
plasma concentrations of NO3–/NO2– (the relatively
stable metabolite of NO) 6 hours after initiation of CLP.
Such vascular hyporeactivity was corrected by L-nitro-
arginine methyl ester plus 1400W [N-(3-(aminomethyl)
benzyl) acetamidine hydrochloride, a selective inducible
NO synthase (iNOS) inhibitor]. However, prophylac-
tic imipenem did not alter NO production or vascular
contractility after sepsis induced by CLP. The authors
suggested that a higher dose of antibiotics and longer
duration of treatment might be required.
During sepsis, the vascular responsiveness can vary
in different vascular beds. Among these, the portal–
systemic collateral vascular bed is also worth in-
vestigating because the results might be applied to
gastroesophageal varices, the most prominent collateral
vasculature in cirrhotic patients. In our previous study,
an in situ collateral perfusion model was used to sur-
vey the alteration of collateral vascular reactivity to LPS
in portal hypertensive rats. To our surprise, LPS elic-
ited time-dependent portal–systemic collateral vascular
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responsiveness to arginine vasopressin (AVP).9 Com-
pared with saline-injected portal-vein-ligated rats,
decreased perfusion pressure change (i.e. a poorer
vasoconstrictive response to AVP) occurred 30 min-
utes after LPS injection. However, higher perfusion
pressure changes that denoted enhanced AVP response
developed at 90 minutes, and were further aggravated
5 hours post-LPS. This is consistent with a previous
study that showed an increased vasoconstrictive re-
sponse to AVP in rat cremaster muscle microvessels at
90 minutes after induction of endotoxemia.10 Taking
systemic hemodynamics into consideration, compared
with the saline-injected group, when tachycardia that
suggested early-stage shock developed (90 minutes
post-LPS injection), the initial poorer vasoconstrictive
AVP response at 30 minutes turned out to be stronger.
That is, when systemic hypotension ensued at 5 hours,
the AVP response was exaggerated.9 These results raised
our interest in whether or not, in endotoxemic shock,
the portal–systemic collaterals, like most resistance ves-
sels, constrict in an attempt to compensate for sys-
temic hypotension and divert their blood flow to vital
tissues. Liao et al8 showed that the poorer superior
mesenteric arterial vascular responsiveness developed
at 6 hours and 18 hours after CLP in portal hyperten-
sive rats. The various time-dependent changes might
have been related to different experimental designs for
different vascular beds. Nevertheless, they reflect the
complexity of vascular response alteration with the
progression of sepsis.
Liao et al8 also reported enhanced NO production
6 hours after initiation of CLP-induced sepsis in por-
tal hypertensive rats, as compared with control portal
hypertensive rats without sepsis. In our recent survey,9
we found that portal hypertensive rats, 30 minutes post-
LPS administration, had higher splenorenal shunting
(the most prominent intra-abdominal portal–systemic
collateral vessel) and endothelial NOS expression than
the control group with saline injection. At 90 minutes
and 5 hours post-injection, enhanced splenorenal
shunt iNOS and endothelin-1 expression (a vascular
endothelium-derived potent vasoconstrictive substance)
were observed in the LPS group. Liao et al8 also indi-
cated that the augmented NO overproduction by
iNOS resulted in further vascular hyporesponsiveness
in portal vein-ligated rats 6 hours after CLP. Taken
together, these results indicate that iNOS plays a major
role in increased NO production at this stage after the
induction of sepsis.
Because portal hypertensive and cirrhotic patients are
frequently afflicted by endotoxemia, bacterial translo-
cation and sepsis, the clarification of vascular responsive-
ness in sepsis does contribute much to a better control
of gastroesophageal variceal bleeding. However, more
data are urgently required to clarify the whole course
and to build up the mechanism. Although it might not
be possible to extrapolate the results of animal studies
to clinical practice at present, accumulating evidence
is paving the way.
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